JP2013517758A5 - - Google Patents

Download PDF

Info

Publication number
JP2013517758A5
JP2013517758A5 JP2012513400A JP2012513400A JP2013517758A5 JP 2013517758 A5 JP2013517758 A5 JP 2013517758A5 JP 2012513400 A JP2012513400 A JP 2012513400A JP 2012513400 A JP2012513400 A JP 2012513400A JP 2013517758 A5 JP2013517758 A5 JP 2013517758A5
Authority
JP
Japan
Prior art keywords
myc
seq
variant
human
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012513400A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013517758A (ja
JP5827220B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2011/051685 external-priority patent/WO2011090221A1/en
Publication of JP2013517758A publication Critical patent/JP2013517758A/ja
Publication of JP2013517758A5 publication Critical patent/JP2013517758A5/ja
Application granted granted Critical
Publication of JP5827220B2 publication Critical patent/JP5827220B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012513400A 2010-01-22 2011-01-21 人工多能性幹細胞の樹立効率改善方法 Active JP5827220B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28232010P 2010-01-22 2010-01-22
US61/282,320 2010-01-22
PCT/JP2011/051685 WO2011090221A1 (en) 2010-01-22 2011-01-21 Method for improving induced pluripotent stem cell generation efficiency

Publications (3)

Publication Number Publication Date
JP2013517758A JP2013517758A (ja) 2013-05-20
JP2013517758A5 true JP2013517758A5 (enExample) 2014-03-06
JP5827220B2 JP5827220B2 (ja) 2015-12-02

Family

ID=44307020

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012513400A Active JP5827220B2 (ja) 2010-01-22 2011-01-21 人工多能性幹細胞の樹立効率改善方法

Country Status (4)

Country Link
US (1) US9005967B2 (enExample)
EP (1) EP2526189B1 (enExample)
JP (1) JP5827220B2 (enExample)
WO (1) WO2011090221A1 (enExample)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9732319B2 (en) 2010-12-22 2017-08-15 Fate Therapeutics, Inc. Cell culture platform for single cell sorting and enhanced reprogramming of iPSCs
DK2951290T3 (en) 2013-02-01 2018-01-22 Us Health PROCEDURE FOR PREPARING RETINAL PIGMENTAL EPIT (RPE) CELLS FROM INDUCED PLURIPOTENT STEM CELLS (IPSCS)
EP3766962B1 (en) 2013-02-06 2025-10-22 University of Rochester Induced pluripotent cell-derived oligodendrocyte progenitor cells for the treatment of myelin disorders
CN120536341A (zh) * 2014-03-04 2025-08-26 菲特治疗公司 改良的重编程方法和细胞培养平台
US9724432B2 (en) 2015-04-30 2017-08-08 University Of Rochester Non-human mammal model of human degenerative disorder, uses thereof, and method of treating human degenerative disorder
CN114807035B (zh) 2015-09-08 2024-02-02 (由卫生与公众服务部部长代表的)美利坚合众国 临床级别视网膜色素上皮细胞的可再现的分化方法
US11162070B2 (en) 2015-09-08 2021-11-02 FUJIFILM Cellular Dynamics, Inc. MACS-based purification of stem cell-derived retinal pigment epithelium
CN117737124A (zh) 2015-10-16 2024-03-22 菲特治疗公司 用于诱导和维护基态多能性的平台
WO2017070333A1 (en) 2015-10-20 2017-04-27 Cellular Dynamics International, Inc. Multi-lineage hematopoietic precursor cell production by genetic programming
AU2017290805B2 (en) 2016-07-01 2023-11-16 Research Development Foundation Elimination of proliferating cells from stem cell-derived grafts
EP3491134B1 (en) 2016-08-01 2023-10-11 University of Pittsburgh - of The Commonwealth System of Higher Education Human induced pluripotent stem cells for high efficiency genetic engineering
CA3038690A1 (en) 2016-10-05 2018-04-12 FUJIFILM Cellular Dynamics, Inc. Generating mature lineages from induced pluripotent stem cells with mecp2 disruption
US11458225B2 (en) 2016-11-09 2022-10-04 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services 3D vascularized human ocular tissue for cell therapy and drug discovery
AU2018220843B2 (en) 2017-02-14 2023-09-21 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Methods of engineering human induced pluripotent stem cells to produce liver tissue
CN110891967B (zh) 2017-04-18 2025-03-14 富士胶片细胞动力公司 抗原特异性免疫效应细胞
JP2020517259A (ja) 2017-04-19 2020-06-18 ボード・オブ・リージエンツ,ザ・ユニバーシテイ・オブ・テキサス・システム 操作された抗原受容体を発現する免疫細胞
EP3621434B1 (en) 2017-05-10 2026-07-15 University of Rochester Glial progenitor cells for use in treating schizophrenia
WO2019204817A1 (en) 2018-04-20 2019-10-24 FUJIFILM Cellular Dynamics, Inc. Method for differentiation of ocular cells and use thereof
CN112566640A (zh) 2018-06-18 2021-03-26 罗切斯特大学 治疗精神分裂症和其他神经精神病症的方法
US12303549B2 (en) 2018-06-21 2025-05-20 University Of Rochester Methods of treating or inhibiting onset of Huntington's disease
CN112912492A (zh) * 2018-07-02 2021-06-04 林希龙 活体外诱导成体干细胞增殖及分化
CA3119041A1 (en) 2018-11-19 2020-05-28 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Biodegradable tissue replacement implant and its use
AU2019386140B2 (en) 2018-11-28 2026-05-28 Board Of Regents, The University Of Texas System Multiplex genome editing of immune cells to enhance functionality and resistance to suppressive environment
EP3886874B1 (en) 2018-11-29 2024-12-11 Board of Regents, The University of Texas System Methods for ex vivo expansion of natural killer cells and use thereof
AU2019396450B2 (en) 2018-12-11 2025-08-28 University Of Rochester Methods of treating schizophrenia and other neuropsychiatric disorders
EP3923962A2 (en) 2019-02-13 2021-12-22 University of Rochester Gene networks that mediate remyelination of the human brain
WO2021092657A1 (en) 2019-11-13 2021-05-20 Monash University Methods for reprogramming cells
EP4118234A1 (en) 2020-03-09 2023-01-18 FUJIFILM Corporation Markers specific for pluripotent stem cells, and methods of using the same
IL298254A (en) 2020-05-29 2023-01-01 Fujifilm Cellular Dynamics Inc Double layer of retinal pigment epithelium and photoreceptors and their uses
KR20230019453A (ko) 2020-05-29 2023-02-08 후지필름 셀룰러 다이내믹스, 인코포레이티드 망막 색소 상피 세포 및 광수용체의 이중 세포 응집체 및 이의 사용 방법
CA3201499A1 (en) 2020-11-13 2022-05-19 Catamaran Bio, Inc. Genetically modified natural killer cells and methods of use thereof
JP2023550453A (ja) 2020-11-18 2023-12-01 富士フイルム株式会社 セクレトーム含有組成物の生成、並びにその使用及び分析方法
US12060581B2 (en) 2020-11-24 2024-08-13 Monash University Methods and cellular structures
AU2021389671A1 (en) 2020-11-24 2023-06-22 Monash University Induced stem cells
EP4251645A1 (en) 2020-11-25 2023-10-04 Catamaran Bio, Inc. Cellular therapeutics engineered with signal modulators and methods of use thereof
US20220306991A1 (en) 2021-03-25 2022-09-29 Bluerock Therapeutics Lp Methods for obtaining induced pluripotent stem cells
WO2022251443A1 (en) 2021-05-26 2022-12-01 FUJIFILM Cellular Dynamics, Inc. Methods to prevent rapid silencing of genes in pluripotent stem cells
WO2022251499A1 (en) 2021-05-28 2022-12-01 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods to generate macular, central and peripheral retinal pigment epithelial cells
JP2024520423A (ja) 2021-05-28 2024-05-24 ザ ユナイテッド ステイツ オブ アメリカ, アズ リプレゼンテッド バイ ザ セクレタリー, デパートメント オブ ヘルス アンド ヒューマン サービシーズ 弱接着細胞を収容するための二次マトリックスを有する生分解性組織スキャフォールド
EP4402249A1 (en) 2021-09-13 2024-07-24 Fujifilm Cellular Dynamics, Inc. Methods for the production of committed cardiac progenitor cells
US20230241118A1 (en) 2021-10-20 2023-08-03 University Of Rochester Rejuvenation treatment of age-related white matter loss
CA3235105A1 (en) 2021-10-20 2023-04-27 Steven A. Goldman Humanized chimeras for the prospective assessment of glial cell addition or replacement therapy
US20230226116A1 (en) 2021-10-20 2023-07-20 University Of Rochester Method for rejuvenating glial progenitor cells and rejuvenated glial progenitor cells per se
CA3236365A1 (en) 2021-11-02 2023-05-11 University Of Rochester Tcf7l2 mediated remyelination in the brain
US20250161495A1 (en) 2022-02-01 2025-05-22 University Of Rochester Methods of generating a population of neurons from human glial progenitor cells and genetic constructs for carrying out such methods
WO2023172514A1 (en) 2022-03-07 2023-09-14 Catamaran Bio, Inc. Engineered immune cell therapeutics targeted to her2 and methods of use thereof
WO2023215455A1 (en) 2022-05-05 2023-11-09 University Of Rochester Dual macroglial-microglial approach towards therapeutic cell replacement in neurodegenerative and neuropsychiatric disease
US20240003871A1 (en) 2022-06-29 2024-01-04 FUJIFILM Cellular Dynamics, Inc. Ipsc-derived astrocytes and methods of use thereof
WO2024073776A1 (en) 2022-09-30 2024-04-04 FUJIFILM Cellular Dynamics, Inc. Methods for the production of cardiac fibroblasts
EP4658294A2 (en) 2023-02-02 2025-12-10 University of Rochester Competitive replacement of glial cells
WO2024192329A1 (en) 2023-03-16 2024-09-19 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods for producing stable human chondroctyes and their use for promoting cartillage growth and repair
WO2025245202A1 (en) 2024-05-21 2025-11-27 FUJIFILM Cellular Dynamics, Inc. Particle counting and biomass measurements of aggregated cell compositions
US20260146229A1 (en) 2024-11-27 2026-05-28 Bluerock Therapeutics Lp Photoreceptor precursor cell (prp) compositions and uses thereof
WO2026117659A1 (en) 2024-11-27 2026-06-04 Bluerock Therapeutics Lp Methods of treating inherited retinal diseases
US20260226420A1 (en) 2025-01-31 2026-08-06 FUJIFILM Holdings America Corporation Methods for the production of hepatic stellate cells from human pluripotent stem cells

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4937190A (en) 1987-10-15 1990-06-26 Wisconsin Alumni Research Foundation Translation enhancer
ES2296413T3 (es) 1998-06-08 2008-04-16 Osiris Therapeutics, Inc. Regulacion de la diferenciacion de celulas madre hematopoyeticas por el uso de celulas madre mesenquimaticas humanas.
WO2000070070A1 (en) 1999-05-18 2000-11-23 Dnavec Research Inc. Paramyxoviridae virus vector defective in envelope gene
US6602711B1 (en) 2000-02-21 2003-08-05 Wisconsin Alumni Research Foundation Method of making embryoid bodies from primate embryonic stem cells
JP3660601B2 (ja) 2001-03-30 2005-06-15 独立行政法人科学技術振興機構 胚性幹細胞からの神経幹細胞、運動ニューロン及びgaba作動性ニューロンの製造法
JP2004121165A (ja) 2002-10-07 2004-04-22 Asahi Kasei Corp 膵幹様細胞の分化誘導方法
US20090227032A1 (en) 2005-12-13 2009-09-10 Kyoto University Nuclear reprogramming factor and induced pluripotent stem cells
EP2206724A1 (en) 2005-12-13 2010-07-14 Kyoto University Nuclear reprogramming factor
DK3399025T3 (da) 2007-03-23 2025-06-16 Wisconsin Alumni Res Found Omprogrammering af somatiske celler
AU2008297024B2 (en) 2007-10-31 2014-08-28 Kyoto University Nuclear reprogramming method

Similar Documents

Publication Publication Date Title
JP2013544069A5 (enExample)
JP2011529330A5 (enExample)
JP2015506673A5 (enExample)
JP2012518988A5 (enExample)
JP2011525793A5 (enExample)
JP2013505701A5 (enExample)
JP2016185172A5 (enExample)
RU2018137842A (ru) Агонисты рецепторов глюкагона/glp-1 для лечения ожирения
RU2018112719A (ru) Способы и препараты для трансфекции клеток
JP2011182800A5 (enExample)
JP2018534922A5 (enExample)
JP2012527887A5 (enExample)
RU2012101874A (ru) Получение индуцированных плюрипотентных стволовых клеток из пуповинной крови
JP2014240404A5 (enExample)
IL238505A (en) Human or fragmented cxcr5 antibody, nucleic acid encoding it, vector containing nucleic acid, cell containing vector, use of cxcr5 antibody for drug preparation, antibody containing method and antibody preparation method
JP2012501680A5 (enExample)
WO2013059524A3 (en) Antibodies directed against influenza
WO2009015284A3 (en) Il-18 receptor antigen binding proteins
WO2009069655A1 (ja) 管理サーバ、クライアント端末、端末管理システム、端末管理方法、プログラム、及び、記録媒体
RU2016106583A (ru) Пептиды, способные реактивировать мутанты р53
HRP20171694T1 (hr) Novi pripravci i postupci
JP2016513457A5 (enExample)
WO2011153981A3 (de) Verfahren zur herstellung einer organnachbildung, insbesondere eines funktionsmodells
JP2024547057A5 (enExample)
EA201400192A1 (ru) Клетка, ферментирующая пентозы